Aytu BioScience is a specialty healthcare company that focuses on developing and commercializing novel products in the field of urology in the United States. The company’s products include Natesto, The MiOxsys System, Prostascint and Aytu Women’s Health. Natesto is the first and only FDA approved intranasal testosterone replacement therapy. While ProstaScint is the only commercially available diagnostic imaging agent approved by the FDA that specifically targets prostate cancer. The company is based in Englewood, Colorado.